Inventor

BERMUDES DAVID GORDON

US46 patents

⚠️ This page may combine multiple inventors who share the name “BERMUDES DAVID GORDON”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BERMUDES DAVID GORDON

BERMUDES DAVID GORDON

Protease inhibitor: protease sensitivity expression system and method improving the therapeutic activity and specificity of proteins and phage and phagemids delivered by bacteria

Protease inhibitor: protease sensitivity expression system composition and methods improving the therapeutic activity and specificity of proteins delivered by bacteria

Immunization and/or treatment of parasites and infectious agents by live bacteria

Live bacterial vaccines resistant to carbon dioxide (CO2), acidic PH and/or osmolarity for viral infection prophylaxis or treatment

Protease inhibitor: protease sensitivity expression system and method improving the therapeutic activity and specificity of proteins and phage and phagemids delivered by bacteria

Protease inhibitor: protease sensitivity expression system composition and methods improving the therapeutic activity and specificity of proteins delivered by bacteria

Live bacterial vaccines for viral infection prophylaxis or treatment

Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine

Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity

Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity

Protease inhibitor: protease sensitive expression system composition and methods improving the therapeutic activity and specificity of proteins delivered by bacteria

Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity

Bacteria carrying bacteriophage and protease inhibitors for the treatment of disorders and methods of treatment

Bacterial methionine analogue and methionine synthesis inhibitor anticancer, antiinfective and coronary heart disease protective microcins and methods of treatment therewith

Live bacterial vectors for prophylaxis or treatment

Immunization and/or treatment of parasites and infectious agents by live bacteria

Live bacterial vaccines resistant to carbon dioxide (CO2), acidic pH and/or osmolarity for viral infection prophylaxis or treatment

Bacterial methionine analogue and methionine synthesis inhibitor anticancer, antiinfective and coronary heart disease protective microcins and methods of treatment therewith

Topical and orally administered protease inhibitors and bacterial vectors for the treatment of disorders and methods of treatment

Copper chelation therapeutics

Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity

Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity

Live bacterial vectors for prophylaxis or treatment

Immunization and/or treatment of parasites and infectious agents by live bacteria

Live bacterial vaccines resistant to carbon dioxide (CO2), acidic pH and/or osmolarity for viral infection prophylaxis or treatment

Compositions and methods for determining successful immunization by one or more vaccines

Protease inhibitor: protease sensitive expression system and method improving the therapeutic activity and specificity of proteins and phage and phagemids delivered by bacteria

Protease inhibitor combination with therapeutic proteins including antibodies

Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated Salmonella as a vaccine

Protease inhibitor: protease sensitive expression system and method improving the therapeutic activity and specificity of proteins and phage and phagemids delivered by bacteria

Bacteria carrying bacteriophage and protease inhibitors for the treatment of disorders and methods of treatment

Topical and orally administered protease inhibitors and bacterial vectors for the treatment of disorders and methods of treatment

Copper chelation therapeutics

Bacteria carrying bacteriophage and protease inhibitors for the treatment of disorders and methods of treatment

Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity

Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity

Protease inhibitor:protease sensitive expression system and method improving the therapeutic activity and specificity of proteins and phage and phagemids delivered by bacteria

Protease inhibitor:protease sensitive expression system, composition and methods for improving the therapeutic activity and specificity of proteins delivered by bacteria

Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria

Chimeric protein toxins for expression by therapeutic bacteria

Immunization and/or treatment of parasites and infectious agents by live bacteria

Protease inhibitor combination with therapeutic proteins including antibodies

Chimeric protein toxins for expression by therapeutic bacteria

Bacteria having boolean control pathways expressing therapeutic proteins including immunotherapeutic cytotoxins

Chimeric protein toxins for expression by therapeutic bacteria

AVIEX TECHNOLOGIES LLC

Live bacterial vaccines for prophylaxis or treatment of infection